Boy, 4, Fights Rare Meningococcal Infection in Israel

A four-year-old boy from Holon is hospitalized in serious condition at Wolfson Medical Center after contracting invasive meningococcal disease, a rare and aggressive bacterial infection.

The child arrived at the pediatric emergency room with rapidly developing symptoms. Medical tests confirmed he was suffering from an invasive infection caused by the meningococcus bacterium.

Dr. Diana Tasher, director of the pediatric department at Wolfson Medical Center, described the case as involving one of the most violent and dangerous infections in pediatric medicine. "The meningococcus bacterium can attack a completely healthy person and within just a few hours lead to organ failure, septic shock, and a genuine life-threatening situation," she explained.

According to Dr. Tasher, the bacterium resides in the throat of 10%-20% of the population and sometimes transitions from a carrier state to active disease. In certain cases, the bacterium penetrates the bloodstream or nervous system, causing meningitis or sepsis.

The Challenge of Rapid Diagnosis

Dr. Tasher emphasized the major challenge in identifying the disease in its early stages. "The initial signs are non-specific and closely resemble a regular viral illness, fever, weakness, muscle aches, or headache, but the pace at which the disease escalates is dramatic. Within just 24 to 48 hours, the patient's condition can deteriorate into a severe illness, so any delay in diagnosis or treatment can be critical."

The disease strikes with highest frequency in children aged zero to two years, and populations living in crowded conditions or those who are immunocompromised are also at increased risk, according to the physician.

She called on parents and medical teams to remain vigilant and recognize warning signs. "A stiff neck, lethargy, or petechial rash, red-purple spots that don't disappear when pressed, constitute classic warning signs. If these are identified, immediate medical attention in an emergency room is required," she stressed.

She also clarified that a vaccine against meningococcus strain B, called Bexsero, is available in Israel. This is the most common strain in the country. The vaccine is not included in the routine immunization schedule but is highly recommended for all children up to age five, particularly up to age two.

The child's condition is now stable, and he continues to receive medical treatment in the pediatric department at Wolfson Medical Center.